Cannabis Products Related News
New Frontier Data launches first virtual Global Cannabis Town Hall
Amidst the current global COVID-19 outbreak and the ensuing cancellation of all conferences, New Frontier Data will be holding a virtual Global Cannabis Town...
Drug Science partnership to improve patient access to medical cannabis
Drug Science Medical Cannabis Working Group has formed a partnership with a leading British producer of medical cannabis to help improve patients access to...
Rize ETF: Europe’s most diversified cannabis equity portfolio
Four new companies have been added to Rize ETF’s specialist thematic Exchange Traded Fund (ETF) to create Europe’s most diversified cannabis equity portfolio.
Rize ETF,...
Symtomax: poised for a head start in the European cannabis market
A Portuguese cannabis company, Symtomax, is positioning itself to become the biggest supplier of medical cannabis in the European cannabis market.
Symtomax, a medical cannabis...
Cosaint Nectar: unleashing the power of CBDA
Cosaint Nectar CEO Philip Tarazi details the unique benefits of CBDA and how Cosaint’s industry leading innovation can support pain management.
If you have not...
Cymra Life Sciences: pioneering tissue culture for novel pain medicines
Cymra Life Sciences is pioneering plant science research to create superior cannabis pain relief medicines.
Australian life sciences company Cymra Life Sciences is harnessing science...
CanPharma: bridging the gap between plant and patients
With a team of medical experts and seasoned pharmaceutical entrepreneurs, CanPharma is set to drive innovation and to set new standards for optimal treatment...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria
Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns.
Arge Canna is the primary...
The NCIA talks policy, equality and regulation in US cannabis
National Cannabis Industry Association Media Relations Director Morgan Fox tells MCN about regulation, policy reform and representation in the field of US cannabis.
The National...
Spektrum Cannabis Technologies: making the complex simple
Spektrum Technologies eliminates the need for new facility construction and building retrofitting by housing large scale extraction equipment in transportable, regulatory compliant units.
Spektrum Cannabis...
Root Sciences: nanoemulsification and the beverage revolution
By adding nanoemulsion systems to its line of hemp and cannabis processing equipment, Root Sciences is (yet again) changing the industry’s approach to producing...
LeafCann: common misconceptions about cannabis
LeafCann Group CEO Elisabetta Faenza explores harmful myths around medical and adult use cannabis.
Leafcann is aware that perhaps no other plant causes as much...
Rize ETF: separating the medical cannabis science from the hype
Rahul Bhushan, co-founder of European exchange-traded fund issuer Rize ETF, discusses global trends in medical cannabis regulation.
The world of cannabis is full of unlikely...
Medicaleaf: the clarion call for wellness from nature
The Medicaleaf team share their observations and understanding of the driving forces of increasing consumer demand for CBD.
Medicaleaf™ aspires to be a philanthropic and...
Emerald Clinics: co-creating evidence with medical cannabis patients
Emerald Clinics CEO Dr Michael Winlo highlights the unique benefits of building real world evidence bases in patient-focussed clinical practice.
Emerald Clinics' asks 'why haven’t...
PURE5 extraction: new trends in cannabis oil production
PURE5 powered by COMERG offers innovative emerging solutions for the safe, clean extraction of high-quality cannabis product.
Cannabis oils, also called terpenes, are derived from...
Cryo Cure: Perfecting the cannabis drying and curing process
Cryo Cure CEO Tracee McAfee showcases the benefits of freeze drying in cannabis production.
For decades, freeze drying has been a long discussed, but never...
Revolutionising cannabis cultivation with world-first SNP chip
The word’s-first SNP chip has been developed to help breeders with cultivation by improving the consistency of chemical profiling and disease resistant characteristics of...
Symtomax: what’s the next step for medical cannabis innovation?
Paul Segal, chairman and co-founder of Symtomax, showcases Symtomax’s contribution to innovations in the medical cannabis sector.
2020 is looking to be a remarkable year...
Calls for CBD regulation following inaccurate CBD levels on products
The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...